相关实验视频
Updated: Jul 26, 2026

14:45
Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
Published on: August 6, 2014
有证据表明,在男性生殖系中,致病性FGFR2突变具有选择性优势
Anne Goriely1, Gilean A T McVean, Maria Röjmyr
1Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK.
概括
人类精子突变随着父亲的年龄增加而增加,但高水平来自罕见事件. 矛盾的是,有害的FGFR2突变可能在产生精子的细胞中受到青.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 人类的繁殖和发展 人类的繁殖和发展
- 分子生物学分子生物学
背景情况:
- 人类配体中的突变率显示出男性偏见,并随着父亲年龄的增加而增加.
- 以前对这种偏差的解释包括复制错误和低效的DNA修复.
- 直接研究这些与年龄相关的突变动态一直是具有挑战性的.
研究的目的:
- 开发一种敏感的方法来量化精子中的特定基因突变.
- 研究父亲年龄与纤维细胞生长因子受体2 (FGFR2) 基因突变之间的关系.
- 探索驱动突变积累和潜在选择性压力的潜在机制.
主要方法:
- 开发了一种敏感的试验,用于量化人类精子中的FGFR2基因在特定位置 (位置755) 的核酸替代.
- 分析了父亲年龄与这些FGFR2突变的频率之间的相关性.
- 评估了高频突变的起源,区分频繁和不频繁的突变事件.
主要成果:
- 精子中的FGFR2基因核酸755的替代水平随着父亲的年龄增加而增加.
- 即使观测到的高突变频率也来自于不常见的,特定的突变事件.
- 该研究确定了携带FGFR2突变的精子细胞的潜在选择性优势.
结论:
- 证实了与年龄相关的FGFR2突变在精子中的增加,源于罕见事件.
- 有害的FGFR2突变可能在精子中具有矛盾的丰富性,这是由于精子细胞获得的选择性优势.
- 这一发现为雄性性交配体中突变偏差背后的机制提供了新的视角.
相关概念视频
X-linked Traits
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
Sex-linked Disorders
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
The Ratio of X Chromosome to Autosomes
In most organisms, sex is determined by the ratio of X and Y chromosomes. However, in some organisms, such as Drosophila and C.elegans, sex is determined by the ratio of the number of X chromosomes to the number of sets of autosomes. The Y chromosome in Drosophila is active but does not determine sex. It contains genes responsible for the production of sperms in adult flies.
Normal male Drosophila has a ratio of one X chromosome to two sets of autosomes. In contrast, normal female Drosophila...
Normal male Drosophila has a ratio of one X chromosome to two sets of autosomes. In contrast, normal female Drosophila...
Complementation Tests
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

